We initially analysed the cell surface expression of CD123 on blasts from paediatric patients diagnosed at our institution, proving that CD123 is expressed in the majority of AML cases in the total blast population and in the fraction of CD34+ cells, which is presumed to contain LSCs. Here, CD34 is linked to acute myeloid leukemia.